May 1 (UPI) --Pharmaceutical giant Johnson & Johnson on Wednesday said it is taking steps to resolve a multibillion dollar, cancer-related lawsuit with thousands of individuals over claims that ...
Aaron McDade is a breaking news reporter for Investopedia. He is an experienced journalist who has covered everything from the latest in business and tech news to sports and international news ...
Johnson and Johnson reiterated in its statement on Wednesday, May 1, that “none of the talc-related claims against it have merit” getty Stock image of baby powder Johnson & Johnson has offered ...
Benzinga - by Vandana Singh, Benzinga Editor. Wednesday, Johnson & Johnson (NYSE:JNJ) announced its intention to proceed with a $6.475 billion settlement to resolve numerous lawsuits related to ...
Pharmaceutical giant Johnson & Johnson is set to pay $6.475 billion to settle lawsuits alleging its talc-based products, often associated with health concerns, caused cancer. This unprecedented ...
Five plaintiffs sued Johnson & Johnson on Wednesday, accusing the company of fraud through its use of a shell company's ...
Johnson & Johnson must pay $260 million (€238 million) to an Oregon woman who said she got mesothelioma, a deadly cancer linked to asbestos exposure, from inhaling the company's talc powder, a ...
A jury has ruled that Johnson & Johnson JNJ must pay $260 million to an Oregon woman who claims to have developed mesothelioma from using the company’s talc powder. What Happened: The jury’s ...
Johnson and Johnson revealed lower earnings and sales numbers than expected in Q4 2022 Even before Q4 numbers were released, JNJ started falling after a slew of new stories hit the press Even ...
Titans WR Andre Johnson is retiring. The 35-year-old made his legacy with the Texans, where he is by far the franchise leader in receiving yards and receptions.
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and ...